Sheng Ma
No. 899, Pinghai Street
Suzhou, 215006, China
Suzhou, 215006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Metabolic Stability and Metabolic Profile of Schisandrol B in Rat and Human Liver Microsomes Employing HPLC-MS/MS Analysis.
Journal: Rapid communications in mass spectrometry : RCM
Published: March 27, 2026
Absorption, distribution, metabolism, excretion and mass balance of ainuovirine, a non-nucleoside reverse transcriptase inhibitor in humans.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: November 12, 2025
Effects of Voriconazole on the Safety, Pharmacokinetics and Pharmacodynamics of Ciprofol (HSK3486), a Novel Intravenous Anaesthetic, in Healthy Participants: A Prospective, Randomized, Crossover Clinical Trial.
Journal: Drug design, development and therapy
Published: October 10, 2025
Mass balance and metabolite profiles in humans of tegoprazan, a novel potassium-competitive acid blocker, using 14C-radiolabelled techniques.
Journal: Expert opinion on drug metabolism & toxicology
Published: May 11, 2025
Pharmacokinetics, mass balance, and metabolism of [14C]FCN-437c, a selective and potent CDK4/6 inhibitor in humans.
Journal: Cancer chemotherapy and pharmacology
Published: February 22, 2025
Maternal Exposure to Polystyrene Nanoplastics Disrupts Spermatogenesis in Mouse Offspring by Inducing Prdm14 Overexpression in Undifferentiated Spermatogonia.
Journal: ACS nano
Published: January 10, 2025
Polydopamine-based nano-protectant for prolonged boar semen preservation by eliminating ROS and regulating protein phosphorylation via D2DR-mediated cAMP/PKA signaling pathway.
Journal: Journal of nanobiotechnology
Published: September 03, 2024
Investigation of absorption, metabolism, and excretion of [14C]pruxelutamide (GT0918), an androgen receptor antagonist in humans.
Journal: British journal of clinical pharmacology
Published: August 20, 2024
Pharmacokinetics, Mass Balance, and Biotransformation of [14C]tinengotinib, A Novel Multi-target Kinase Inhibitor, in Healthy Subjects.
Journal: Drugs in R&D
Published: August 19, 2024
ATF3 as a response factor to regulate Cd-induced reproductive damage by activating the NRF2/HO-1 ferroptosis pathway.
Journal: Ecotoxicology and environmental safety
Published: July 24, 2024
Absorption, metabolism, and excretion of oral [14C] radiolabeled donafenib: an open-label, phase I, single-dose study in humans.
Journal: Cancer chemotherapy and pharmacology
Published: May 27, 2024
Last Updated: 09/26/2026